XLV241011C177500
- 0.04
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
J&J Discontinues Phase 2 Study for Bladder Cancer Drug TAR-200
How Is The Market Feeling About Abbott Laboratories?
Morgan Stanley's List of Tax Loss Selling Stocks
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
Merck & Co Analyst Ratings
Amgen Analyst Ratings
AbbVie Analyst Ratings
10 Health Care Stocks Whale Activity In Today's Session
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
(TMO) - Analyzing Thermo Fisher Scientific's Short Interest
Pfizer Stock Climbs 4% Amid Reports Starboard Has Taken $1B Stake
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Ahead of Q3 Earnings Season
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
Regeneron Co-founder Warns of Harms From Weight-loss Drugs: FT
Can Novo, Lilly Take Credit for U.S. Obesity Rate Decline?
Trending Stocks This Week as Strong Jobs Report Underscore Resilience of U.S. Economy
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
Looking Into Danaher's Recent Short Interest